RVNC Revance Announces Transformative Aesthetics Portfolio Transaction with Exclusive U.S. Distribution Agreement of FDA-Approved Dermal Fillers from TEOXANE SA- TEOXANE SARHA® portfolio: first and only range of FDA-approved dermal fillers for correction of dynamic wrinkles -- Revance gains access to the growing $1.1B U.S. filler market with three differentiated products, and plans to launch in second quarter 2020 -- Fast-tracks Revance’s commercial organization, and strengthens the anticipated launchof DaxibotulinumtoxinA for Injection (DAXI), the company’s next-generation neuromodulator -- Conference call and webcast today at 8:30 a.m. ET - https://investors.revance.com/news-releases/news-release-details/revance-announces-transformative-aesthetics-portfolio
Bien aprovechado! Hace un par de meses que tiene movimientos muy locos, y no le hace falta ni offerings ni news para ello. Está muy maja para trading (si se tiene la habilidad suficiente, claro...).CLVS